Wall Street analysts predict that Guardant Health Inc (NASDAQ:GH) will report ($0.36) earnings per share for the current quarter, Zacks reports. Three analysts have provided estimates for Guardant Health’s earnings, with the highest EPS estimate coming in at ($0.30) and the lowest estimate coming in at ($0.40). The firm is scheduled to announce its next quarterly earnings results on Monday, February 18th.
On average, analysts expect that Guardant Health will report full year earnings of ($1.12) per share for the current year, with EPS estimates ranging from ($1.16) to ($1.10). For the next financial year, analysts forecast that the business will report earnings of ($1.26) per share, with EPS estimates ranging from ($1.30) to ($1.24). Zacks’ earnings per share averages are a mean average based on a survey of sell-side research firms that that provide coverage for Guardant Health.
Guardant Health (NASDAQ:GH) last released its quarterly earnings results on Monday, November 19th. The company reported ($1.94) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.29) by ($1.65). The firm had revenue of $21.70 million for the quarter, compared to analyst estimates of $17.44 million. The company’s revenue was up 95.5% compared to the same quarter last year.
Shares of NASDAQ:GH traded up $1.24 during trading on Friday, reaching $38.40. The stock had a trading volume of 393,151 shares, compared to its average volume of 368,008. Guardant Health has a one year low of $27.04 and a one year high of $44.25.
About Guardant Health
Guardant Health, Inc, a precision oncology company, provides non-invasive cancer diagnostics. It offers liquid biopsy tests for advanced stage cancer, such as Guardant360, a molecular diagnostic test that measures various cancer-related genes from circulating tumor DNA (ctDNA); and GuardantOMNI, a broader panel measuring various genes from ctDNA.
Read More: Moving Average (MA)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Guardant Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guardant Health and related companies with MarketBeat.com's FREE daily email newsletter.